Clinical Trial Update: Functional Microscale Organotypic Assays to Predict Patient Response to Anti-Angiogenesis Therapies [Phase 2]

View source ↗

Summary

Phase 2 trial investigating functional microscale organotypic assays to predict patient response to anti-angiogenesis therapies in renal cell carcinoma; study t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Renal Cell Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2022-12-21